NO954389L - Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte - Google Patents

Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte

Info

Publication number
NO954389L
NO954389L NO954389A NO954389A NO954389L NO 954389 L NO954389 L NO 954389L NO 954389 A NO954389 A NO 954389A NO 954389 A NO954389 A NO 954389A NO 954389 L NO954389 L NO 954389L
Authority
NO
Norway
Prior art keywords
salt
squalene synthetase
synthetase inhibitor
phosphonosulfonate
inhibitor salts
Prior art date
Application number
NO954389A
Other languages
English (en)
Norwegian (no)
Other versions
NO954389D0 (no
Inventor
Yadagiri Pendri
Chung Pin Chen
David J Kucera
Eduardo J Martinez
Paul D Pansegrau
John K Thottathil
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO954389D0 publication Critical patent/NO954389D0/no
Publication of NO954389L publication Critical patent/NO954389L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075Esters with hydroxyalkyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
NO954389A 1994-11-03 1995-11-02 Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte NO954389L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33366194A 1994-11-03 1994-11-03

Publications (2)

Publication Number Publication Date
NO954389D0 NO954389D0 (no) 1995-11-02
NO954389L true NO954389L (no) 1996-05-06

Family

ID=23303735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954389A NO954389L (no) 1994-11-03 1995-11-02 Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte

Country Status (14)

Country Link
EP (1) EP0710665A1 (de)
JP (1) JPH08208672A (de)
KR (1) KR960017680A (de)
CN (1) CN1130188A (de)
AU (1) AU3458795A (de)
CA (1) CA2159850A1 (de)
CZ (1) CZ279595A3 (de)
FI (1) FI955256A (de)
HU (1) HUT73140A (de)
IL (1) IL115537A0 (de)
NO (1) NO954389L (de)
PL (1) PL311218A1 (de)
TW (1) TW318852B (de)
ZA (1) ZA959326B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780974B1 (fr) * 1998-07-08 2001-09-28 Sod Conseils Rech Applic Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
WO2002038180A1 (fr) * 2000-11-09 2002-05-16 Takeda Chemical Industries, Ltd. Agent haute densite faisant monter le taux de lipoproteine-cholesterol
CN101198252A (zh) 2005-04-18 2008-06-11 加利福尼亚大学董事会 用于细菌感染的抗微生物疗法
JP5161872B2 (ja) 2006-05-12 2013-03-13 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア 細菌感染に対する抗微生物療法
CN101580472B (zh) * 2009-06-24 2013-07-10 广西壮族自治区化工研究院 1,1'-联-2-萘酚的拆分剂以及拆分方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ248852A (en) * 1992-10-28 1997-06-24 Squibb & Sons Inc Alpha-phosphono and phosphinosulphonates and medicaments thereof
US5312814A (en) * 1992-12-09 1994-05-17 Bristol-Myers Squibb Co. α-phosphonocarboxylate squalene synthetase inhibitors

Also Published As

Publication number Publication date
FI955256A (fi) 1996-05-04
HUT73140A (en) 1996-06-28
NO954389D0 (no) 1995-11-02
TW318852B (de) 1997-11-01
CA2159850A1 (en) 1996-05-04
EP0710665A1 (de) 1996-05-08
CN1130188A (zh) 1996-09-04
AU3458795A (en) 1996-05-09
PL311218A1 (en) 1996-05-13
KR960017680A (ko) 1996-06-17
CZ279595A3 (en) 1996-08-14
HU9503136D0 (en) 1995-12-28
FI955256A0 (fi) 1995-11-02
JPH08208672A (ja) 1996-08-13
ZA959326B (en) 1997-05-05
IL115537A0 (en) 1996-01-19

Similar Documents

Publication Publication Date Title
DE69105495D1 (en) Benzylphosphonsäure-tyrosinkinaseinhibitoren.
EG20693A (en) Isoxazoline compounds as antiinflammatory agents
WO1996040745A3 (en) Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
CA2282654A1 (en) Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder
AU6328094A (en) Saccharin derivative proteolytic enzyme inhibitors
SG52659A1 (en) Saccharin derivative proteolytic enzyme inhibitors
BR0010220A (pt) Compostos de pirimidinona
CA2144372A1 (en) Composition for water treatment
FI971974A0 (fi) Tienopyridiini- tai tienopyrimidiinijohdannaiset ja niiden käyttö
MY116539A (en) New amino acid derivatives
BR9916272A (pt) 4 e 5-alquiniloxindóis e 4 e 5-alqueniloxindóis
CA2020858A1 (en) Water treatment agent and water treatment method for boiler
FI953157A0 (fi) Ympärist¦lietteen käsittelymenetelmä
NO954389L (no) Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte
MX9704575A (es) Compuestos quimicos.
MA23790A1 (fr) Procede pour desactiver ou detruire des microorganismes
DK0712278T3 (da) N-pyridyltoluidinholdigt svampedræbende, vanddispergerbart granulat
NO982081L (no) Syntetiske mineralmikropartikler og retensjonshjelpemidler og vannbehandlingssystemer og fremgangsmÕter ved anvendelse av slike partikler
MY112593A (en) A storage stable water solution for infusion containing a thrombin inhibitor
AU7063287A (en) A composition for inhibiting corrosion in industrial cooling waters and a method for improving the performance of corrosion inhibitors in same
MX9202015A (es) Esteres aril alquilicos de acido 4,5-di hidroxi -9,10- di hidro-9,10-di oxo --2- antracen carboxilico que tienen actividad terapeutica.
AU5121199A (en) Processes for producing highly pure nicotinamide
PT1019347E (pt) Metodo para a sintese de taxanos
Searle et al. Mutation to neostigmine resistance in a cholinesterase-containing Pseudomonas
ZA982808B (en) Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia